Orbital involvement in langerhans cell histiocytosis

Houman Vosoghi, Carlos Rodriguez-Galindo, Matthew Wilson

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Purpose: The authors studied a series of patients with Langerhans cell histiocytosis in an attempt to better define the incidence and significance of orbital involvement within the vast spectrum of the disease. Methods: Retrospective chart review of consecutive patients with a recorded diagnosis of Langerhans cell histiocytosis treated at St. Jude Children's Research Hospital between 1992 and 2007. Pertinent information included age, gender, clinical features, radiological features, treatment, disease progression, orbital involvement, and development of diabetes insipidus. Results: The authors found and evaluated 24 patients (16 male). The median age at diagnosis was 24 months (range, 4-179 months), and median follow-up was 75 months (range, 6-186 months). Nine (37.5%) patients had orbital involvement (6 on presentation, 3 on subsequent follow-up). The 2 patients with unifocal orbital lesions developed progressive disease. All patients with orbital lesions received systemic chemotherapy either at the time of diagnosis (n = 8) or on documented disease progression (n = 1). Six patients (25%), 2 of whom had orbital involvement, developed diabetes insipidus in the setting of either multibone (n = 1) or multisystem (n = 5) disease. Conclusions: In this study, orbital involvement occurred in one third of patients with Langerhans cell histiocytosis, usually in the context of multifocal bone or multisystem disease. Thus, the authors believe a comprehensive workup and follow-up in the context of a multidisciplinary approach is necessary. The authors found that the response to local curretage or steroid injection for small lesions, and to systemic chemotherapy for extensive lesions, is usually excellent and that aggressive local control measures, such as surgical resection or radiation, are not indicated in most cases.

Original languageEnglish (US)
Pages (from-to)430-433
Number of pages4
JournalOphthalmic Plastic and Reconstructive Surgery
Volume25
Issue number6
DOIs
StatePublished - Nov 1 2009

Fingerprint

Langerhans Cell Histiocytosis
Diabetes Insipidus
Disease Progression
Drug Therapy
Steroids
Radiation
Bone and Bones
Injections
Incidence

All Science Journal Classification (ASJC) codes

  • Ophthalmology
  • Surgery

Cite this

Orbital involvement in langerhans cell histiocytosis. / Vosoghi, Houman; Rodriguez-Galindo, Carlos; Wilson, Matthew.

In: Ophthalmic Plastic and Reconstructive Surgery, Vol. 25, No. 6, 01.11.2009, p. 430-433.

Research output: Contribution to journalArticle

Vosoghi, Houman ; Rodriguez-Galindo, Carlos ; Wilson, Matthew. / Orbital involvement in langerhans cell histiocytosis. In: Ophthalmic Plastic and Reconstructive Surgery. 2009 ; Vol. 25, No. 6. pp. 430-433.
@article{a8a5f54a410f41b985f6502a0d5ee331,
title = "Orbital involvement in langerhans cell histiocytosis",
abstract = "Purpose: The authors studied a series of patients with Langerhans cell histiocytosis in an attempt to better define the incidence and significance of orbital involvement within the vast spectrum of the disease. Methods: Retrospective chart review of consecutive patients with a recorded diagnosis of Langerhans cell histiocytosis treated at St. Jude Children's Research Hospital between 1992 and 2007. Pertinent information included age, gender, clinical features, radiological features, treatment, disease progression, orbital involvement, and development of diabetes insipidus. Results: The authors found and evaluated 24 patients (16 male). The median age at diagnosis was 24 months (range, 4-179 months), and median follow-up was 75 months (range, 6-186 months). Nine (37.5{\%}) patients had orbital involvement (6 on presentation, 3 on subsequent follow-up). The 2 patients with unifocal orbital lesions developed progressive disease. All patients with orbital lesions received systemic chemotherapy either at the time of diagnosis (n = 8) or on documented disease progression (n = 1). Six patients (25{\%}), 2 of whom had orbital involvement, developed diabetes insipidus in the setting of either multibone (n = 1) or multisystem (n = 5) disease. Conclusions: In this study, orbital involvement occurred in one third of patients with Langerhans cell histiocytosis, usually in the context of multifocal bone or multisystem disease. Thus, the authors believe a comprehensive workup and follow-up in the context of a multidisciplinary approach is necessary. The authors found that the response to local curretage or steroid injection for small lesions, and to systemic chemotherapy for extensive lesions, is usually excellent and that aggressive local control measures, such as surgical resection or radiation, are not indicated in most cases.",
author = "Houman Vosoghi and Carlos Rodriguez-Galindo and Matthew Wilson",
year = "2009",
month = "11",
day = "1",
doi = "10.1097/IOP.0b013e3181b80cad",
language = "English (US)",
volume = "25",
pages = "430--433",
journal = "Ophthalmic Plastic and Reconstructive Surgery",
issn = "0740-9303",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Orbital involvement in langerhans cell histiocytosis

AU - Vosoghi, Houman

AU - Rodriguez-Galindo, Carlos

AU - Wilson, Matthew

PY - 2009/11/1

Y1 - 2009/11/1

N2 - Purpose: The authors studied a series of patients with Langerhans cell histiocytosis in an attempt to better define the incidence and significance of orbital involvement within the vast spectrum of the disease. Methods: Retrospective chart review of consecutive patients with a recorded diagnosis of Langerhans cell histiocytosis treated at St. Jude Children's Research Hospital between 1992 and 2007. Pertinent information included age, gender, clinical features, radiological features, treatment, disease progression, orbital involvement, and development of diabetes insipidus. Results: The authors found and evaluated 24 patients (16 male). The median age at diagnosis was 24 months (range, 4-179 months), and median follow-up was 75 months (range, 6-186 months). Nine (37.5%) patients had orbital involvement (6 on presentation, 3 on subsequent follow-up). The 2 patients with unifocal orbital lesions developed progressive disease. All patients with orbital lesions received systemic chemotherapy either at the time of diagnosis (n = 8) or on documented disease progression (n = 1). Six patients (25%), 2 of whom had orbital involvement, developed diabetes insipidus in the setting of either multibone (n = 1) or multisystem (n = 5) disease. Conclusions: In this study, orbital involvement occurred in one third of patients with Langerhans cell histiocytosis, usually in the context of multifocal bone or multisystem disease. Thus, the authors believe a comprehensive workup and follow-up in the context of a multidisciplinary approach is necessary. The authors found that the response to local curretage or steroid injection for small lesions, and to systemic chemotherapy for extensive lesions, is usually excellent and that aggressive local control measures, such as surgical resection or radiation, are not indicated in most cases.

AB - Purpose: The authors studied a series of patients with Langerhans cell histiocytosis in an attempt to better define the incidence and significance of orbital involvement within the vast spectrum of the disease. Methods: Retrospective chart review of consecutive patients with a recorded diagnosis of Langerhans cell histiocytosis treated at St. Jude Children's Research Hospital between 1992 and 2007. Pertinent information included age, gender, clinical features, radiological features, treatment, disease progression, orbital involvement, and development of diabetes insipidus. Results: The authors found and evaluated 24 patients (16 male). The median age at diagnosis was 24 months (range, 4-179 months), and median follow-up was 75 months (range, 6-186 months). Nine (37.5%) patients had orbital involvement (6 on presentation, 3 on subsequent follow-up). The 2 patients with unifocal orbital lesions developed progressive disease. All patients with orbital lesions received systemic chemotherapy either at the time of diagnosis (n = 8) or on documented disease progression (n = 1). Six patients (25%), 2 of whom had orbital involvement, developed diabetes insipidus in the setting of either multibone (n = 1) or multisystem (n = 5) disease. Conclusions: In this study, orbital involvement occurred in one third of patients with Langerhans cell histiocytosis, usually in the context of multifocal bone or multisystem disease. Thus, the authors believe a comprehensive workup and follow-up in the context of a multidisciplinary approach is necessary. The authors found that the response to local curretage or steroid injection for small lesions, and to systemic chemotherapy for extensive lesions, is usually excellent and that aggressive local control measures, such as surgical resection or radiation, are not indicated in most cases.

UR - http://www.scopus.com/inward/record.url?scp=73949147035&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73949147035&partnerID=8YFLogxK

U2 - 10.1097/IOP.0b013e3181b80cad

DO - 10.1097/IOP.0b013e3181b80cad

M3 - Article

VL - 25

SP - 430

EP - 433

JO - Ophthalmic Plastic and Reconstructive Surgery

JF - Ophthalmic Plastic and Reconstructive Surgery

SN - 0740-9303

IS - 6

ER -